Outcome of laparoscopic resection for rectal cancer through the data of 346 patients in 108 Military Central Hospital

  • Triệu Triều Dương Bệnh viện Trung ương Quân đội 108
  • Lê Văn Quốc Bệnh viện Trung ương Quân đội 108
  • Diêm Đăng Bình Bệnh viện Trung ương Quân đội 108
  • Hồ Hữu An Bệnh viện Trung ương Quân đội 108
  • Trần Tuấn Linh Bệnh viện Trung ương Quân đội 108
  • Nguyễn Văn Trưởng Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

Rectal cancer, laparoscopic resection, neoadjuvant chemoradiation therapy

Abstract

Objective: To evaluate the results of laparoscopic rectal cancer resection. Subject and method: A cross-sectional, descriptive study, over 346 rectal cancer patients undergoing laparoscopic resection in 108 Military Central Hospital from June 2018 to October 2020. Result: Male/ female: 2.2/1, the mean age was 61.8 ± 11.9 years. The rate of neoadjuvant chemoradiation therapy (NCT) was 79.7%. Preoperative period I, II, III were 13.0%, 15.6%, 71.4%, respectively. Open surgical conversion rate of 2.6%. The mean operative time was 125.9 minutes, the mean blood loss was 63.9ml. The rate of Miles surgery in the middle and lower rectal cancer group with NCT was 20.2%. Postoperative stage 0, I, II, III were 17.5%, 56.4%, 9.1%, 17.0%, respectively. Average follow - up time 17.8 months. The rate of complication after surgery was 14%. The mortality rate was 2.6%. The rate of local recurrence was 4.3%. The rate of distal metastasis was 3.8%. Conclusion: The laparoscopic rectal cancer resection is feasible, safe, effective. Neoadjuvant chemoradiation therapy to reduce the tumor stage, to increase the rate of sphincter preservation.

Article Details

References

1. Japanese Society for Cancer of the Colon and Rectum, Hashiguchi Y, Muro K et al (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25(1): 1-42.
2. Glynne-Jones R, Wyrwicz L, Tiret E et al (2017) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 28: 22-40.
3. National Comprehensive Cancer Network (NCCN) (2017) Clinical practice guidelines on oncology. Rectal cancer version 3.2017.pdf.
4. Campos FG (2013) The life and legacy of William Ernest Miles (1869-1947): A tribute to an admirable surgeon. Revista da Associação Médica Brasileira 59(2): 181-185.
5. Heald RJ, Husband EM and Ryall RDH (1982) The mesorectum in rectal cancer surgery the clue to pelvic recurrence?. Br J Surg 69(10): 613-616.
6. Lange MM, Rutten HJ and van de Velde CJH (2009) One hundred years of curative surgery for rectal cancer: 1908-2008. European Journal of Surgical Oncology (EJSO) 35(5): 456–463.
7. Lujan J, Valero G, Biondo S et al (2013) Laparoscopic versus open surgery for rectal cancer: Results of a prospective multicentre analysis of 4,970 patients. Surg Endosc 27(1): 295-302.
8. Memon MA, Awaiz A, Yunus RM et al (2018) Meta-analysis of histopathological outcomes of laparoscopic assisted rectal resection (LARR) vs open rectal resection (ORR) for carcinoma. The American Journal of Surgery 216(5): 1004-1015.
9. George JC (2018) Rectal Cancer Modern Approaches to Treatment. © Springer International Publishing AG 2018.
10. David EB, Steven DW, Janice FR (2019) Gordon and nivatvongs’ principles and practice of surgery for the Colon, Rectum, and Anus. © 2019 Thieme Medical Publishers, Inc.